SCHEMBL23278779

SCHEMBL23278779

Cc1cc(-c2ncccc2I)ccn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 2/20 0.42
▸ NFATC1 O95644 1/20 0.41
▸ UHRF1 Q96T88 1/20 0.41
▸ MAPK14 Q16539 3/20 0.39
▸ CCNC P24863 2/20 0.39
▸ CDK8 P49336 2/20 0.39
▸ MAPK13 O15264 1/20 0.38
▸ GCGR P47871 1/20 0.38
▸ MAPK12 P53778 1/20 0.38
▸ MAPK11 Q15759 1/20 0.38
▸ MAP4K4 O95819 3/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ TDO2 P48775 2/20 0.36
▸ CDC7 O00311 1/20 0.36
▸ ROCK2 O75116 1/20 0.36
▸ CDK2 P24941 1/20 0.36
▸ GSK3B P49841 1/20 0.36
▸ CLK4 Q9HAZ1 1/20 0.36
▸ MKNK2 Q9HBH9 1/20 0.36
▸ IRAK4 Q9NWZ3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22886304 0.81 CYP2A6 (0.55) DYRK1AUHRF1MAPK14MAPK1CYP2A6
SCHEMBL28051935 0.79 KDM4E (0.51) DYRK1AUHRF1MAPK14CCNCCDK8
SCHEMBL28829364 0.76 MAP4K4 (0.44) DYRK1AUHRF1MAPK14MAP4K4MAPK1
SCHEMBL19961426 0.75 CYP11B1 (0.44) DYRK1AMAPK14MAPK13MAPK12MAPK11
SCHEMBL31092839 0.73 HDAC8 (0.45) MAPK14MAPK1CYP2A6MTOR
SCHEMBL29249875 0.73 HDAC8 (0.45) MAPK14MAPK1CYP2A6MTOR
SCHEMBL1896511 0.73 DYRK1A (0.65) DYRK1ANFATC1UHRF1CCNCCDK8
SCHEMBL30308690 0.73 DYRK1A (0.65) DYRK1ANFATC1UHRF1CCNCCDK8
SCHEMBL5700281 0.72 KDM4E (0.47) TDO2CYP2A6MTOR
SCHEMBL12145551 0.72 WNT3A (0.51) DYRK1AUHRF1MAPK1IRAK4CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10988447-B2 Bipyridine derivatives and their uses for organic light emitting diodes SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-04-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10988447-B2 Bipyridine derivatives and their uses for organic light emitting diodes CRY2, CRY1, CCNA1 DYRK1A 4107/4885NFATC1 4795/4885UHRF1 2184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback